Get the Stockscreener App
5.77
3.50%
0.195
After Hours:
5.70
-0.07
-1.21%
Lifemd Inc stock is traded at $5.77, with a volume of 2.77M.
It is up +3.50% in the last 24 hours and down -15.89% over the past month.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
See More
Previous Close:
$5.575
Open:
$5.85
24h Volume:
2.77M
Relative Volume:
2.61
Market Cap:
$243.44M
Revenue:
$193.06M
Net Income/Loss:
$-22.51M
P/E Ratio:
-9.0156
EPS:
-0.64
Net Cash Flow:
$10.63M
1W Performance:
+15.63%
1M Performance:
-15.89%
6M Performance:
+10.33%
1Y Performance:
-31.15%
1-Day Range:
$5.495
$6.50
1-Week Range:
$4.125
$6.50
52-Week Range:
$3.99
$12.88
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Compare LFMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMD
Lifemd Inc
|
5.77 | 243.44M | 193.06M | -22.51M | 10.63M | -0.64 |
|
VEEV
Veeva Systems Inc
|
233.46 | 37.90B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
74.01 | 12.80B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
64.30 | 12.07B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
95.78 | 8.30B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
45.50 | 7.84B | 640.44M | -743.28M | -206.93M | -11.29 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Initiated | Lake Street | Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-23-24 | Resumed | B. Riley Securities | Buy |
| Jun-05-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-30-23 | Initiated | Craig Hallum | Buy |
| Jul-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-03-23 | Initiated | H.C. Wainwright | Buy |
| Mar-10-22 | Initiated | Colliers Securities | Buy |
| Oct-04-21 | Resumed | B. Riley Securities | Buy |
View All
Lifemd Inc Stock (LFMD) Latest News
LifeMD stock target raised to $14 by H.C. Wainwright - Investing.com India
LifeMD Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
LifeMD’s (LFMD) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World
Cantor Fitzgerald maintains LifeMD stock at Overweight, $15 target By Investing.com - Investing.com Australia
LifeMD, Inc. Reports Strong Telehealth Growth Amid Challenges - TipRanks
LifeMD, Inc. SEC 10-K Report - TradingView
LifeMD Inc. (LFMD) reports earnings - Quartz
LifeMD, Inc. (NASDAQ:LFMD) Q4 2024 Earnings Call Transcript - Insider Monkey
Top Premarket Gainers -March 11, 2025 at 07:54 am EDT - Marketscreener.com
KeyBanc maintains Overweight rating on LifeMD shares By Investing.com - Investing.com South Africa
KeyBanc maintains Overweight rating on LifeMD shares - Investing.com
LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions - Yahoo Finance
LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Reven - GuruFocus.com
Earnings call transcript: LifeMD beats Q4 2024 expectations, stock surges By Investing.com - Investing.com Canada
LifeMD, Inc. Reports Strong Q4 2024 Results - TipRanks
LifeMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
LifeMD reports Q4 EPS 21c vs. 14c last year - TipRanks
LifeMD Inc Outlook Q1 2025 Total Revenue In The Range Of $61 Million To $63 Million - Marketscreener.com
Earnings call transcript: LifeMD beats Q4 2024 expectations, stock surges - Investing.com
LifeMD Q4 Revenue USD 64.3 Million Versus. Ibes Estimate USD 57.4 Million -March 10, 2025 at 05:31 pm EDT - Marketscreener.com
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
LifeMD Reports Fourth Quarter 2024 Results - GlobeNewswire
LifeMD earnings beat by $0.26, revenue topped estimates - Investing.com Canada
LifeMD Reports Fourth Quarter 2024 Results - GlobeNewswire Inc.
LIFEMD Earnings Results: $LFMD Reports Quarterly Earnings - Nasdaq
LifeMD stock soars 16% on earnings beat, strong guidance By Investing.com - Investing.com Canada
LifeMD stock soars 16% on earnings beat, strong guidance - Investing.com India
LifeMD options imply 11.7% move in share price post-earnings - TipRanks
When Would Be The Best Time To Buy LifeMD Inc (NASDAQ: LFMD) Stock? - Stocks Register
LifeMD, Inc. (NASDAQ:LFMD) Receives $11.14 Average PT from Brokerages - Defense World
Rhumbline Advisers Raises Stock Position in LifeMD, Inc. (NASDAQ:LFMD) - Defense World
It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks - Simply Wall St
LifeMD Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
LifeMD, Inc. (LFMD): A Bull Case Theory - MSN
LifeMD Inc (LFMD) Q4 2024: Everything You Need to Know Ahead of Earnings - GuruFocus.com
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound - MSN
LifeMD and Teladoc Health partner with LillyDirect pharmacy provider Gifthealth for Zepbound - MSN
Two telehealth firms turn to branded Zepbound as restrictions loom on copies - Reuters
Teladoc, LifeMD partner with Eli Lilly on GLP-1s - Modern Healthcare
LifeMD announces integration with LillyDirect pharmacy provider - TipRanks
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound -March 06, 2025 at 09:14 am EST - Marketscreener.com
LifeMD Integrates With LillyDirect to Offer Access of Single-dose Vials of Zepbound - MarketWatch
Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound - Marketscreener.com
LifeMD to Offer Zepbound Through LillyDirect Partnership -March 06, 2025 at 08:43 am EST - Marketscreener.com
LifeMD integrates with Gifthealth for obesity treatment access - Investing.com India
LifeMD® Announces Integration with LillyDirect Pharmacy - GlobeNewswire
Can LifeMD's New Lilly Partnership Transform Patient Access to Zepbound? - StockTitan
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum - GlobeNewswire
Can LifeMD's Upcoming Investor Presentation Reveal New Growth Strategies? - StockTitan
LifeMD (LFMD) to Release Earnings on Monday - Defense World
Kaskela Law LLC Announces Important Deadline in Shareholder Class Action Lawsuit Against LifeMD, Inc. (LFMD) and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm - ACCESS Newswire
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.01%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):